PTEN loss in sporadic mutations also leads to obesity with retained insulin sensitivity (79), which is consistent with its position downstream of the insulin pathway, inhibiting PI3K/AKT/mTOR pathway. The gene discussed is PTEN; the disease is obesity due to melanocortin 4 receptor deficiency.